Topics:

JAMA paper delves into Merck staph vaccine flunk

Tools

A paper in JAMA has revealed details of the Merck ($MRK) Staphylococcus aureus vaccine trial that was stopped early in 2011 amid safety concerns. The vaccine was no more effective than a placebo, and was associated with a rise in multiorgan failure. Article

Filed Under

Comments